The Default Mode Network and How Ketamine Treats Depression

The Brain's Internal Narrative System

The default mode network (DMN) is a system of interconnected brain regions that activates when the mind is at rest — not engaged with external tasks — and turns inward. It is the neural infrastructure underlying daydreaming, self-reflection, autobiographical memory, and the ongoing internal narrative that defines each person's sense of who they are. While this capacity for self-referential thought is fundamental to human experience, research over the past two decades has revealed that in depression, the DMN becomes overactive, excessively connected, and locked into patterns of negative self-focused thinking.

The discovery that ketamine acutely disrupts this pathological DMN activity — and that this disruption is associated with antidepressant effects — has provided one of the most compelling neurobiological frameworks for understanding how ketamine treats depression.

Anatomy of the Default Mode Network

Core Regions

The DMN consists of several brain regions that consistently activate together during rest and self-referential processing:

• Medial prefrontal cortex (mPFC) — Involved in self-evaluation, social cognition, and integrating personal significance into experience. Hyperactivity in this region during depression is associated with excessive self-critical thinking.
• Posterior cingulate cortex (PCC) and precuneus — Central hubs of the DMN involved in autobiographical memory retrieval, spatial and temporal self-orientation, and awareness of the internal environment. The PCC is one of the most metabolically active brain regions at rest.
• Angular gyrus (lateral parietal cortex) — Involved in semantic processing, attention, and the integration of sensory and conceptual information.
• Medial temporal lobe (including hippocampus) — Contributes autobiographical memories to the self-referential processing stream.

Connectivity

These regions do not function in isolation — they form a coherent network through strong functional connections (correlated patterns of neural activity). The strength and patterns of connectivity within the DMN can be measured using functional magnetic resonance imaging (fMRI), and these measurements have become a powerful tool for studying the neurobiology of depression.

How the DMN Functions in Healthy Brains

In healthy individuals, the DMN serves essential cognitive functions:

• Self-continuity: Maintaining a coherent sense of identity across time by linking past memories, present awareness, and future anticipation
• Social cognition: Understanding the perspectives, emotions, and intentions of others (theory of mind)
• Creative thinking: The mind-wandering facilitated by the DMN contributes to creative problem-solving and insight
• Emotional regulation: Healthy self-reflection helps process and integrate emotional experiences

Critically, in healthy brains, the DMN deactivates smoothly when attention shifts to external tasks. This dynamic switching between the DMN and task-positive networks (such as the dorsal attention network and the central executive network) allows for flexible cognitive engagement with both internal and external demands.

The DMN in Depression: A Network Gone Awry

Hyperactivation

Functional neuroimaging studies have consistently demonstrated that the DMN is hyperactive in individuals with major depression. This hyperactivation means that the self-referential processing system is chronically "on" — generating a continuous stream of internally directed, self-focused thought even when the individual is attempting to engage with the external world.

Hyperconnectivity

Beyond hyperactivation, the connections within the DMN are excessively strong in depression. This hyperconnectivity creates a tightly coupled network that resists modulation — the DMN essentially becomes "sticky," maintaining its activated state even when other networks should be taking over.

Impaired Deactivation

One of the most clinically significant DMN abnormalities in depression is the failure to deactivate appropriately during task engagement. Healthy individuals show robust DMN suppression when they begin a cognitive task, allowing attention to shift fully to the external demand. In depression, this deactivation is incomplete, meaning the self-referential stream continues to run in the background — intruding on attention, undermining concentration, and maintaining the grip of negative self-focused thinking.

Rumination: The Clinical Consequence

What Rumination Is

Rumination — the repetitive, passive focus on one's symptoms of distress, their causes, and their consequences — is the primary clinical manifestation of DMN hyperactivity in depression. It is characterized by:

• Repetitive thinking about past failures, losses, or inadequacies
• Self-critical evaluation ("What is wrong with me?")
• Passive analysis of one's symptoms rather than active problem-solving
• Difficulty redirecting attention to other topics or activities
• A sense of being mentally "trapped" in negative thought loops

Rumination as a Maintenance Factor

Research has established that rumination is not merely a symptom of depression — it is a maintenance factor that perpetuates and deepens depressive episodes. Ruminative thinking amplifies negative mood, interferes with problem-solving, erodes social support (as individuals withdraw from engagement), and delays recovery. Interventions that reduce rumination, such as mindfulness-based cognitive therapy, have been shown to prevent depressive relapse.

The recognition that DMN hyperactivity drives rumination provides a neurobiological target for treatment — and ketamine's ability to disrupt the DMN offers a pharmacological means of breaking the ruminative cycle. This is especially relevant for patients with treatment-resistant depression who have not responded to conventional approaches targeting serotonin and norepinephrine.

How Ketamine Disrupts the DMN

Acute Effects During Treatment

Neuroimaging studies using fMRI and other techniques have documented the following effects of ketamine on the DMN:

• Reduced within-network connectivity: The tight coupling between DMN regions is loosened, disrupting the self-referential processing stream
• Increased between-network connectivity: The boundaries between the DMN and other networks become more permeable, allowing for more flexible cognitive processing
• Reduced mPFC activity: Activity in the medial prefrontal cortex — the region most associated with negative self-evaluation — decreases during ketamine administration
• Increased entropy: Overall brain signal complexity and variability increase, reflecting a move away from the rigid, repetitive patterns characteristic of depression

The Subjective Experience

The DMN disruption maps closely onto the subjective experience reported by patients during ketamine treatment:

• The sense of detachment from one's usual internal narrative reflects the loosening of DMN connectivity
• The feeling that habitual worry and self-criticism have temporarily lifted corresponds to reduced mPFC activity
• The expanded or unfamiliar quality of consciousness aligns with increased between-network connectivity and global entropy
• The sense of fresh perspective or psychological "reset" that many patients describe after ketamine may reflect the brain's reorganization into less rigid DMN patterns

Post-Treatment Normalization

In patients who respond to ketamine, DMN connectivity patterns begin to normalize in the hours and days following treatment. The hyperconnectivity that characterized the depressive state gives way to more typical connectivity patterns, associated with:

• Reduced rumination
• Improved ability to engage with external activities and relationships
• Greater cognitive flexibility
• Reduced intensity of negative self-referential thoughts

Importantly, this normalization persists beyond the acute pharmacological effects of ketamine, suggesting that the drug triggers a lasting reorganization of network dynamics rather than simply suppressing symptoms while present in the system.

The Broader Network Perspective

Depression as a Network Disorder

The DMN does not operate in isolation. Depression involves disrupted interactions among multiple large-scale brain networks:

• The salience network (anterior insula and dorsal anterior cingulate cortex) — which determines what internal and external signals deserve attention — shows altered function in depression, potentially contributing to the prioritization of negative internal signals
• The central executive network (dorsolateral prefrontal cortex and posterior parietal cortex) — involved in working memory, attention, and goal-directed behavior — shows reduced activation in depression, corresponding to difficulties with concentration and motivation
• The affective network (amygdala and related limbic structures) — involved in emotional processing — shows heightened reactivity to negative stimuli in depression

Ketamine appears to modulate the interactions among all of these networks, not just the DMN. By disrupting the pathological dominance of the DMN and rebalancing inter-network dynamics, ketamine may restore the flexible, adaptive brain function that depression impairs.

Clinical Implications

Timing of Psychotherapy

Understanding the DMN framework has practical implications for integrating ketamine with psychotherapy. The period following ketamine treatment — when the DMN has been disrupted and is reorganizing — may represent an optimal window for psychotherapeutic intervention. Therapies that target rumination and rigid cognitive patterns, such as cognitive behavioral therapy (CBT) and mindfulness-based cognitive therapy (MBCT), may be particularly effective when delivered during this window of enhanced neural flexibility. This principle is central to ketamine-assisted psychotherapy (KAP), which integrates structured therapy with ketamine sessions.

Predicting Treatment Response

DMN connectivity patterns, measured before treatment using resting-state fMRI, have shown preliminary promise as biomarkers for predicting which patients will respond to ketamine. Patients with the most pronounced DMN hyperconnectivity at baseline may be those most likely to benefit from ketamine's network-disrupting effects, though this finding requires replication in larger studies.

Convergence With Other Treatments

The DMN framework reveals commonalities between ketamine and other treatments that modulate the DMN, including psilocybin, meditation, electroconvulsive therapy, and transcranial magnetic stimulation. All of these interventions, despite their different mechanisms, appear to disrupt pathological DMN patterns. This convergence suggests that DMN modulation may be a common pathway for diverse antidepressant treatments. For a broader look at how environment and preparation shape outcomes, see our guide on set and setting.

Note: This article is for educational purposes only and does not constitute medical advice. Individuals considering ketamine therapy for depression should consult with a qualified healthcare provider.

References

• Ketamine's Mechanism of Action: A Path to Rapid-Acting Antidepressants — NIH review of ketamine's neurobiological effects including network-level changes relevant to the DMN
• NIMH: Depression — National Institute of Mental Health overview of depression neurobiology, including brain circuit dysfunction
• StatPearls: Ketamine — Clinical reference on ketamine pharmacology and its effects on brain function
• Ketamine: NMDA Receptors and Beyond — NIH article exploring ketamine's broad receptor interactions and neural network modulation